Related Experiment Video
Updated: Jun 13, 2026
03:37
Cerebral Ischemic Coma Model Induced by Modified Four-Vessel Occlusion
Published on: July 5, 2024
Ergotism with ischemia in all four extremities: a case report
Seok-Young Jeong1, Eui-Seong Lim, Byoung-Soo Shin
1Department of Neurology, Chonbuk National University Medical School, Jeonju, South Korea.
Journal of Clinical Neurology (Seoul, Korea)
|April 17, 2010
Summary
This case study details ergotism, a condition caused by ergotamine, which led to severe ischemia in all four extremities. Prompt management, including medication adjustments and lifestyle changes, successfully resolved the vasospasm.
Area of Science:
- Vascular Medicine
- Neurology
- Toxicology
Background:
- Ergotism is a rare condition resulting from excessive exposure to ergot alkaloids.
- Chronic ergotamine use, often for migraines, can lead to serious vascular complications.
- Ischemia in multiple extremities is a critical presentation of severe ergotism.
Purpose of the Study:
- To report a case of ergotism with widespread limb ischemia.
- To illustrate the diagnostic findings and successful management of this condition.
- To highlight the importance of considering ergotamine toxicity in patients with peripheral vascular symptoms.
Main Methods:
- A 48-year-old male patient with a 21-year history of daily ergotamine use for migraines presented with upper extremity pain and weakness.
- Diagnostic angiography revealed vasospasm in all four extremities.
- Treatment involved intra-arterial prostaglandin infusion, intravenous nitroprusside, smoking cessation, and ergotamine discontinuation.
Main Results:
- Angiography confirmed severe vasospasm affecting all four extremities.
- Partial resolution of vasospasm was observed after prostaglandin infusion.
- Computed tomography angiogram showed normalization of brachial arteries after comprehensive management.
- The patient's symptoms resolved with the implemented treatment strategy.
Conclusions:
- Ergotism can manifest as severe, multi-extremity vasospasm and ischemia.
- A multi-faceted management approach, including cessation of ergotamine and vasodilatory therapies, can effectively reverse these vascular changes.
- This case underscores the critical need for vigilance regarding chronic ergotamine toxicity in patients with peripheral vascular disease symptoms.
Related Concept Videos
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:27Assessment of the Cardiovascular System III: Palpation
Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above the...
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above the...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:29Angina III: Clinical Manifestations and Assessment
Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
01:30Angina I: Introduction
Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
01:26Peripheral Artery Disease IV: Nursing Management
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...